Novartis.com | Contact Us | Help | Site Map | Stay Connected | Large Text VersionRegular Text Version

Welcome to Novartis Oncology - The Global Site for Novartis Oncology

 

 

 

Research & Development

Research Approach

Rational Drug Design

Rational drug design is a focused strategy for drug development that is grounded on a solid foundation in the basic sciences, driven by the rigor of laboratory research, and proven clinically.

Drug Discovery Technology

Novartis Oncology targets are selected based on extensive research to understand the molecular structure of drug receptors, the specific biochemical characteristics of intracellular proteins, the unique products of aberrant genes, and the cellular processes underlying the etiology of cancer.

State-of-the-art technology is used to identify the best compounds to hit specific molecular targets accurately and effectively. When a natural compound is not readily found, synthetic molecules that mimic the natural ligands of receptors can be engineered from the understanding of the underlying mechanisms gleaned from previous research.

Functional Genomics

Working from the roadmap of life - the human genome - researchers have gained an understanding of the complete genetic makeup of human cells, which has provided a new resource for current drug design. The challenge of functional genomics is to understand the function of each gene and its interaction with each of the nearly 30,000 others in the genome.

Tools are now available to facilitate microexperiments that can answer complex questions about each gene in the genome simultaneously. For example, a single experiment can identify the genes that are expressed at high levels in lung tumors, but not in healthy lung tissues.

This type of research can be used to identify molecular targets and compounds, to genetically profile tumors or patients, and in the future, to guide and customize therapeutic choices.

Translational Medicine

Novartis Oncology uses the lessons learned in the laboratory to deliver clinical benefits. Additionally, observations made in clinical settings help to refocus or innovate basic research hypotheses. Active basic and clinical research programs ensure that optimal cancer treatments will be developed as rapidly as possible.

 

PRODUCTS

At Novartis Oncology, we strive to provide a broad range of innovative, practical solutions and authoritative resources.

CAREERS AT NOVARTIS

Careers at Novartis

Our success depends entirely on the creativity, performance and achievement of our associates at all levels.

ABOUT NOVARTIS ONCOLOGY

About Us

We deliver a broad range of innovative therapies, cancer resources and oncology drugs to improve and extend the lives of cancer patients.

CLINICAL TRIALS

Clinical Trials

Our Clinical Trials are crucial in determining the safety and efficacy of new drugs and treatments.

STAY CONNECTED TO THE CANCER RESOURCE CENTER

Receive "Oncology in the News" by email weekly.